BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
26.49
+0.28 (1.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
BridgeBio Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 266.32 | 375.94 | 376.69 | 393.77 | 356.08 | 363.77 | Upgrade
|
| Short-Term Investments | - | 58.95 | 95.23 | 442.89 | 251.01 | 182.22 | Upgrade
|
| Cash & Short-Term Investments | 266.32 | 434.88 | 471.92 | 836.66 | 607.09 | 545.99 | Upgrade
|
| Cash Growth | -50.98% | -7.85% | -43.59% | 37.81% | 11.19% | 25.20% | Upgrade
|
| Accounts Receivable | 0.48 | 1.75 | 17.08 | 19.75 | - | - | Upgrade
|
| Other Receivables | 2.1 | - | - | - | - | 2.85 | Upgrade
|
| Receivables | 2.58 | 1.75 | 17.08 | 19.75 | - | 2.85 | Upgrade
|
| Prepaid Expenses | 28.87 | 13.31 | 21.92 | 32.27 | 35.59 | 19.78 | Upgrade
|
| Restricted Cash | 139.41 | 16.65 | 37.93 | 0.18 | 0.14 | - | Upgrade
|
| Other Current Assets | 7.4 | 11 | - | - | - | - | Upgrade
|
| Total Current Assets | 444.58 | 477.59 | 548.85 | 888.86 | 642.82 | 568.62 | Upgrade
|
| Property, Plant & Equipment | 15.14 | 19.84 | 25.25 | 45.97 | 36.83 | 5.63 | Upgrade
|
| Long-Term Investments | 160.44 | - | - | - | - | 31.14 | Upgrade
|
| Other Intangible Assets | 24.53 | 26.32 | 28.71 | 44.93 | - | - | Upgrade
|
| Other Long-Term Assets | 20.29 | 22.63 | 20.22 | 33.03 | 23.93 | 26.29 | Upgrade
|
| Total Assets | 664.98 | 546.38 | 623.04 | 1,013 | 703.59 | 631.68 | Upgrade
|
| Accounts Payable | 13.36 | 10.66 | 11.56 | 11.88 | 8.95 | 8.85 | Upgrade
|
| Accrued Expenses | 104.7 | 116.97 | 95.54 | 116.75 | 71.9 | 47.46 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 1.46 | - | Upgrade
|
| Current Portion of Leases | 4.6 | 4.13 | 3.68 | 4.94 | 3.8 | - | Upgrade
|
| Current Unearned Revenue | 11.77 | 6.1 | 8.16 | - | - | - | Upgrade
|
| Other Current Liabilities | 4.79 | 6 | 2.5 | 1.5 | 9.55 | 4.08 | Upgrade
|
| Total Current Liabilities | 139.22 | 143.84 | 121.43 | 135.07 | 95.65 | 60.39 | Upgrade
|
| Long-Term Debt | 1,719 | 1,727 | 1,708 | 1,704 | 475.86 | 91.79 | Upgrade
|
| Long-Term Leases | 5.83 | 8.98 | 12.27 | 17.43 | 14.68 | - | Upgrade
|
| Long-Term Unearned Revenue | 18.63 | 3.8 | 7.1 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 1.1 | - | Upgrade
|
| Other Long-Term Liabilities | 0.38 | 5.56 | 19.54 | 22.07 | 8.42 | 3.53 | Upgrade
|
| Total Liabilities | 1,883 | 1,889 | 1,868 | 1,878 | 595.7 | 155.7 | Upgrade
|
| Common Stock | 0.2 | 0.18 | 0.16 | 0.15 | 0.13 | 0.12 | Upgrade
|
| Additional Paid-In Capital | 1,876 | 1,481 | 938.7 | 841.53 | 1,021 | 848.11 | Upgrade
|
| Retained Earnings | -2,831 | -2,561 | -1,918 | -1,437 | -888.76 | -440.03 | Upgrade
|
| Treasury Stock | -275 | -275 | -275 | -275 | -75 | - | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.03 | -0.33 | -0.13 | 0.19 | 0.25 | Upgrade
|
| Total Common Equity | -1,230 | -1,354 | -1,255 | -870.41 | 57.91 | 408.45 | Upgrade
|
| Minority Interest | 11.53 | 11.72 | 9.69 | 4.84 | 49.98 | 67.52 | Upgrade
|
| Shareholders' Equity | -1,218 | -1,343 | -1,245 | -865.58 | 107.89 | 475.98 | Upgrade
|
| Total Liabilities & Equity | 664.98 | 546.38 | 623.04 | 1,013 | 703.59 | 631.68 | Upgrade
|
| Total Debt | 1,730 | 1,740 | 1,724 | 1,726 | 495.79 | 91.79 | Upgrade
|
| Net Cash (Debt) | -1,463 | -1,305 | -1,252 | -889.51 | 111.31 | 485.35 | Upgrade
|
| Net Cash Growth | - | - | - | - | -77.07% | 27.19% | Upgrade
|
| Net Cash Per Share | -8.03 | -8.02 | -8.49 | -6.16 | 0.94 | 4.62 | Upgrade
|
| Filing Date Shares Outstanding | 188.99 | 175.83 | 151.37 | 147.61 | 146.54 | 123.77 | Upgrade
|
| Total Common Shares Outstanding | 188.99 | 175.08 | 150.63 | 147.34 | 122.85 | 123.66 | Upgrade
|
| Working Capital | 305.36 | 333.75 | 427.43 | 753.79 | 547.18 | 508.24 | Upgrade
|
| Book Value Per Share | -6.51 | -7.73 | -8.33 | -5.91 | 0.47 | 3.30 | Upgrade
|
| Tangible Book Value | -1,254 | -1,381 | -1,283 | -915.35 | 57.91 | 408.45 | Upgrade
|
| Tangible Book Value Per Share | -6.64 | -7.89 | -8.52 | -6.21 | 0.47 | 3.30 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.